SQZ BIOTECHNOLOGIES COMPANY
CIK 0001604477
Revenue (TTM)
$9.19M
Q3 Oct 2023
Net Income (TTM)
−$80.74M
−15.6% YoY
Q3 Oct 2023
EPS Diluted (TTM)
−$2.74
−10.8% YoY
Q3 Oct 2023
Gross Margin
—
Q3 Oct 2023
Operating Margin
-895.6%
Q3 Oct 2023
Net Margin
-879.0%
Q3 Oct 2023
Free Cash Flow (TTM)
−$62.56M
Q3 Oct 2023
Cash
$10.19M
Q3 Oct 2023
Total Debt
—
Q3 Oct 2023
Shares Outstanding
29.49M sh
Q3 Oct 2023
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.